RSV Vaccine Linked to Lower Dementia Risk in New Study
A new study highlights that the RSV vaccine Arexvy may reduce dementia risk by 29% within 18 months, adding to evidence that vaccines can have protective effects on brain health.
A recent groundbreaking study from the University of Oxford has revealed that vaccination against respiratory syncytial virus (RSV) may significantly reduce the risk of developing dementia. Published in the journal npj Vaccines, the research indicates that individuals who received the RSV vaccine, Arexvy, experienced a 29% decrease in dementia diagnoses within 18 months post-vaccination. This aligns with previous findings showing that vaccines like shingles (Herpes zoster) vaccine, particularly those containing adjuvants such as Shingrix, also contribute to lowering dementia risk.
The study analyzed health records of over 430,000 people across the U.S. using the TriNetX network. It found that Arexvy, which protects adults over 60 against RSV, shares an adjuvant called AS01 with Shingrix. Both vaccines demonstrated similar effectiveness in decreasing dementia risk, compared to the flu vaccine, which does not contain an adjuvant. The 18-month follow-up showed a notable reduction in dementia cases, regardless of gender.
Although the exact mechanism remains unclear, laboratory studies suggest that the adjuvant AS01 stimulates immune cells that may offer protective effects to the brain, potentially preventing some of the harmful processes associated with dementia. This added benefit may go beyond merely preventing infections like RSV and shingles.
Lead author Associate Professor Maxime Taquet emphasized that these results support the broader benefits of vaccination, not only for preventing specific illnesses but also for reducing the risk of dementia. Senior author Professor Paul Harrison pointed out the importance of further research into how the adjuvant might contribute to this effect.
Overall, these findings suggest that immunization could be a powerful tool in delaying or potentially preventing dementia, a condition with limited treatment options. The study underscores the importance of vaccination as part of a comprehensive approach to health, especially among older adults.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into Memory Preservation: The Roles of Alzheimer's Pathology and Attention in Aging Brains
A recent Stanford study uncovers how early Alzheimer's pathology and attentional focus independently influence memory retention in older adults, highlighting potential avenues for cognitive resilience strategies.
Understanding the Seasonal Dynamics of Disease Spread and Human Behavior
This article explores how seasonal changes and human behavior collectively influence outbreaks of infectious diseases like flu and COVID-19, emphasizing the importance of sustained public health measures to prevent recurrent surges.
Potential of Methylene Blue to Shield Lungs During Major Heart Surgeries: New Research
A new study suggests that methylene blue may protect lungs from damage during complex heart surgeries involving circulatory arrest, offering a promising low-cost intervention to prevent acute lung injury.
Immune Cell Signatures Drive Organ Damage in Systemic Sclerosis
Scientists from Osaka have identified immune cell signatures that are associated with severe organ damage in systemic sclerosis, paving the way for targeted therapies and early diagnosis.